Acutus Medical, Inc. Stock Price, News & Analysis

Welcome to our dedicated page for Acutus Medical news (Ticker: AFIB), a resource for investors and traders seeking the latest updates and insights on Acutus Medical stock.

Acutus Medical, Inc. (AFIB) generates news primarily around its focused role in surgical and medical instrument manufacturing for left-heart access products. Company announcements emphasize that Acutus is centered on the production of left-heart access products under its distribution agreement with Medtronic, Inc., and on capturing potential net-sales earnouts under an asset purchase agreement with Medtronic. News items often explain how this focused business model shapes the company’s financial performance and operational decisions.

Recent press releases have detailed Acutus’ strategic realignment of resources and corporate restructuring, including the decision to wind down its electrophysiology mapping and ablation business and classify those activities as discontinued operations. News coverage includes updates on operational downsizing, workforce reductions, and the company’s efforts to reduce cash burn and ongoing operating expenses while supporting its obligations to Medtronic.

Investors following AFIB news can expect regular financial result announcements, such as quarterly and full-year earnings releases that distinguish between continuing operations in left-heart access manufacturing and discontinued operations in the EP mapping and ablation business. These releases often discuss revenue from continuing operations, gross margin trends related to left-heart access manufacturing, restructuring impacts, and the recording of gains on sale of business tied to the Medtronic agreements.

In addition, Acutus’ news frequently includes outlook statements connected to its realigned business model, commentary from company leadership on strategic priorities, and reminders of the risks highlighted in its forward-looking statements. For those tracking AFIB, this news flow provides context on how the company’s contract manufacturing focus, Medtronic relationship, and restructuring activities influence its ongoing operations and financial profile.